GlassScriptPhysician profile
Isabel Bueno
NPI 1194085415
$7,560.42
in general payments reported to CMS, 2019-2025
38 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,039 · 2020: $737 · 2021: $1,103 · 2022: $1,424 · 2023: $1,846 · 2024: $217 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515 · Travel and Lodging: $711 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.39 |
| Travel and Lodging | $710.71 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,863.05 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $1,541.16 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $816.25 | 2019-2023 | Breztri |
| Lilly USA, LLC | $406.10 | 2019-2023 | Mounjaro, Jardiance |
| Abbvie INC. | $373.53 | 2021-2023 | Ubrelvy, Vraylar |
| Abbott Laboratories | $324.37 | 2019-2024 | Freestyle Libre 3 |
| Pfizer INC. | $287.49 | 2019-2025 | |
| Glaxosmithkline, LLC. | $233.73 | 2019-2025 | Benlysta, Trelegy Ellipta |
| Nevro Corp. | $228.98 | 2020-2022 | |
| Amarin Pharma, INC. | $161.37 | 2019 | |
| Boston Scientific Corporation | $136.95 | 2019-2023 | Watchman Access System |
| Cardiovascular Systems INC. | $129.15 | 2021 | |
| Stryker Corporation | $122.50 | 2023 | Anchorage |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.59 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.08 | 2019-2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Bueno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.